The United States has approved the sale of mifepristone, an
abortion pill, at pharmacies.
Mifepristone is taken in combination with a second drug
called misoprostol to end an intrauterine pregnancy at ten weeks gestation (70
days or less since the first day of a patient’s last menstrual period).
The US Food and Drug Administration (FDA) first approved the
drug in 2000 but patients could only obtain it in person from a health
provider.
On Tuesday, the FDA updated its website with the new requirements for the drug, saying it “can be dispensed by certified pharmacies or by or under the supervision of a certified prescriber”.
A prescription is, however, still required under the new
rule.
The agency said the decision was reached after conducting a
review of the risk evaluation and mitigation strategy (REMS).
“The FDA determined that the available data and information
support modification of the REMS to reduce burden on the health care delivery
system and to ensure the benefits of the product outweigh the risks,” the
agency said.
US pharmacies can now apply for certification to distribute
Mifepristone, which will allow them to directly sell to customers who have a
prescription from a certified prescriber.
The move is said to be an effort by President Joe Biden’s
administration to protect abortion rights following the supreme court’s
decision to overturn the right to abortion, with several states banning or
restricting access to the service.
Women in states where abortion has been banned will likely
need to travel to other states to obtain medication for abortion.
Advertise on NigerianEye.com to reach thousands of our daily users
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com